$5.97
-0.24-3.86%
Last update: Dec 15, 2:18 PM
Comments
Loading...
Aquestive Therapeutics Stock Guidance
AQSTNASDAQ
Aquestive Therapeutics Stock Guidance | NASDAQ:AQST | Benzinga
Aquestive Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/05/2025 | AQST | Aquestive Therapeutics | FY | 2025 | — | — | — | $44.00M | $50.00M | $45.43M | Get Alert |
| 08/11/2025 | AQST | Aquestive Therapeutics | FY | 2025 | — | — | — | $44.00M | $50.00M | $45.14M | Get Alert |
| 05/12/2025 | AQST | Aquestive Therapeutics | FY | 2025 | — | — | — | $44.00M | $50.00M | $49.58M | Get Alert |
| 03/05/2025 | AQST | Aquestive Therapeutics | FY | 2025 | — | — | — | $47.00M | $56.00M | $52.97M | Get Alert |
| 11/04/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $58.01M | Get Alert |
| 09/27/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $58.01M | Get Alert |
| 08/06/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $57.00M | $60.00M | $49.79M | Get Alert |
| 05/07/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $50.21M | Get Alert |
| 03/05/2024 | AQST | Aquestive Therapeutics | FY | 2024 | — | — | — | $48.00M | $51.00M | $48.10M | Get Alert |
| 11/06/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $47.00M | $50.00M | $47.45M | Get Alert |
| 08/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $44.00M | $48.00M | $43.37M | Get Alert |
| 05/02/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $42.00M | $46.00M | $39.06M | Get Alert |
| 03/07/2023 | AQST | Aquestive Therapeutics | FY | 2023 | — | — | — | $37.00M | $41.00M | $37.83M | Get Alert |
| 11/01/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $47.01M | Get Alert |
| 08/02/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $46.00M | $49.00M | $46.46M | Get Alert |
| 05/03/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $48.01M | Get Alert |
| 03/08/2022 | AQST | Aquestive Therapeutics | FY | 2022 | — | — | — | $42.00M | $47.00M | $62.68M | Get Alert |
FAQ
Q
What is the most recent guidance for Aquestive Therapeutics (AQST)?
A
There have been no specific sales or earnings guidance reported for Aquestive Therapeutics in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved